Rosa Nadal Rios, MD, PhD
Associate Professor
Clinical Research Division, Fred Hutch
Dr. Rosa Nadal Rios is a medical oncologist who is devoted to improving the treatment and survival of patients with genitourinary tumors. Her research involves studying novel targeted therapeutics and immunotherapy-based treatments for urologic cancers. Her research interest is in bladder cancer and bringing new cancer cell therapy to treat solid tumor malignancies. In particular, she developed the first clinical trial of engineered T cells targeting human endogenous retrovirus E for kidney cancer. As a native Spanish speaker, Dr. Nadal Rios enjoys working with patients who prefer to communicate in Spanish and advocates for these patients' inclusion in clinical trials.
Other Appointments & Affiliations
Associate Professor, Department of Medicine Division of Hematology and Oncology, University of Washington School of MedicineAssociate Professor, Department of Medicine Division of Hematology and Oncology
University of Washington School of Medicine
Education
Fellowship, Medical Oncology and Hematology, National Institutes of Health, 2016-2018
Post-doctoral Fellowship, Genitourinary Medical Oncology Fellowship, Prostate Cancer Program, Johns Hopkins University, 2013-2016
PhD, School of Medicine, Universitat Autònoma de Barcelona, 2010-2013
Residency, Internal Medicine and Medical Oncology, Hospital de Sant Pau Universitat Autònoma de Barcelona, 2001-2006
MD, School of Medicine, Universitat Autònoma de Barcelona, 2000
Board Certification
Internal Medicine, 2021; Medical Oncology, 2022, American Board of Internal Medicine
"Despite the significant advances in cancer treatment, too many people continue to die prematurely from the disease. Through my research, I honor the patients I've lost and all those, along with their families, who have been affected by cancer."
— Dr. Rosa Nadal Rios